1. 563PUpdated results of phase I study of trastuzumab deruxtecan (DS-8201a) in HER2-expressing advanced colorectal cancer. (23rd October 2018) Authors: Yoshino, T; Iwata, H; Tamura, K; Takahashi, S; Redfern, C; Modi, S; Doi, T; Kawakami, H; Taniguchi, H; Takashima, A; Yamaguchi, K; Fisher, J; Li, B; Saito, K; Fujisaki, Y; Sugihara, M; Tsurutani, J Journal: Annals of oncology Issue: Volume 29(2018)Supplement 8 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PTH-085 Deoxythioguanosine (DTG) in DNA as a Pharmacological Endpoint of Thiopurine Treatment in Inflammatory Bowel Disease Patients. (17th August 2016) Authors: Coulthard, S; Berry, P; McGarrity, S; Kobayashi, T; Toyonaga, T; Ansari, A; Redfern, C Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A261 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. PWE-028 A Novel Assay for The Direct Detection of Deoxythioguanosine (DTG) in DNA from Patients On Azathioprine Using Liquid Chromatography and Tandem Mass Spectrometry (LC-MS/MS). (17th August 2016) Authors: Coulthard, S; Berry, P; McGarrity, S; Redfern, C Journal: Gut Issue: Volume 65(2016)Supplement 1 Page Start: A151 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗